Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cytosorbents Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.027 -- 00:00:06.614 Good day, ladies and gentlemen, and welcome to the Q2 2025 Earnings Conference Call for 00:00:06.614 -- 00:00:11.801 CITO Servants Corp. At this time, all lines are in listen-only mode. 00:00:11.801 -- 00:00:15.305 Following the presentation, we'll conduct a question and answer session. 00:00:15.305 -- 00:00:19.190 If at any time during this call you require automated assistance, please press star zero 00:00:19.190 -- 00:00:24.254 for the operator. This call is being recorded on Wednesday. 00:00:25.338 -- 00:00:30.375 Please, sorry, I would like to return the conference over to Adana Alexander, Investor 00:00:30.375 -- 00:00:33.639 Relations Consultant. Please go ahead. 00:00:33.639 -- 00:00:35.681 Thank you, Sergio, and good afternoon, everyone. 00:00:35.681 -- 00:00:40.826 Welcome to Finest Open's second quarter 2025 financial results and recent business highlights 00:00:40.826 -- 00:00:45.291 conference call. Joining me today from the company for the prepared remarks are Dr. 00:00:45.291 -- 00:00:50.896 Philip Chan, Chief Executive Officer, and Pete Mariani, Chief Financial Officer. 00:00:50.896 -- 00:00:55.001 Before I turn the call over to Dr. Chan, I'd like to remind listeners that during the 00:00:55.001 -- 00:01:00.272 call, management prepared remarks may contain forward-looking statements which are subject 00:01:00.272 -- 00:01:02.816 to risks and uncertainties. 00:01:02.816 -- 00:01:06.201 Management may make additional forward-looking statements in response to your questions 00:01:06.201 -- 00:01:11.289 today. Therefore, the company claims protection under the safe harbor for forward-looking 00:01:11.289 -- 00:01:15.776 statements contained in the Private Securities Litigation Reform Act of 1995. 00:01:15.776 -- 00:01:1...